Baxter Buys Urine Monitoring Co FlowSense for $9.5m

FlowSense
by Globes correspondent (September 10, 2013)

FlowSense’s URINFO fluid monitoring system provides accurate, real-time, and continuous monitoring of urine output.

The Trendlines Group has announced the acquisition of portfolio company Flowsense Medical Ltd. by global healthcare company Baxter International (NYSE: BAX). FlowSense’s URINFO fluid monitoring system provides accurate, real-time, and continuous monitoring of urine output. The company was founded by Trendlines in 2009 and taken public on the Tel Aviv Stock Exchange the following year.

Prior to founding FlowSense, Trendlines acquired the assets upon which the company was established and created a new company to develop and market the company’s products. The company has since sold its products in Europe, the US, Israel, and China. FlowSense generated interest from several potential strategic partners prior to the acquisition by Baxter for $9.5 million, including liabilities

Read the full article on Globes.

News about the FlowSense acquisition appeared in other media.

Leave a Reply